-
公开(公告)号：US20190110983A1
公开(公告)日：2019-04-18
申请号：US16089194
申请日：2017-04-06
申请人： GEDEA BIOTECH AB
发明人： Ulf Ellervik , Olov Sterner , Helena Strevens , Sophie Manner
IPC分类号： A61K9/00 , A61K9/02 , A61K9/20 , A61K31/7004 , A61K31/4174 , A61K31/496 , A61K31/4196 , A61K31/351 , A61K31/513 , A61K31/4164 , A61P31/10
摘要： The present invention relates to a pharmaceutical formulation for vaginal administration, wherein the formulation comprises a pharmaceutical acceptable excipient and glucono δ-lactone, wherein the glucono δ-lactone is present in an amount of 5 to 99 wt % of the formulation. The invention also relates to a pharmaceutical formulation according to the invention for use in the prevention or treatment of a urogenital fungal infection. Furthermore, the invention relates to glucono δ-lactone (formula (III)), for use in the in the prevention or treatment of a fungal infection.
-
公开(公告)号：US11696891B2
公开(公告)日：2023-07-11
申请号：US17218739
申请日：2021-03-31
申请人： Gedea Biotech AB
发明人： Ulf Ellervik , Olov Sterner , Helena Strevens , Sophie Manner
IPC分类号： A61K9/00 , A61K31/366 , F27D1/16 , F27B14/10 , F27B14/06 , A61P31/10 , A61K9/02 , H05B6/24 , A61K9/20 , A61K31/351 , A61K31/4164 , A61K31/496 , A61K31/513 , A61K31/7004 , F27B14/00 , F27B3/12 , A61K31/4174 , A61K31/4196 , F27B14/08
CPC分类号： A61K9/0036 , A61K9/0034 , A61K9/02 , A61K9/20 , A61K31/351 , A61K31/366 , A61K31/4164 , A61K31/4174 , A61K31/4196 , A61K31/496 , A61K31/513 , A61K31/7004 , A61P31/10 , F27B3/12 , F27B14/00 , F27B14/061 , F27B14/10 , F27D1/1626 , H05B6/24 , F27B2014/066 , F27B2014/0837
摘要： The present invention relates to a pharmaceutical formulation for vaginal administration, wherein the formulation comprises a pharmaceutical acceptable excipient and glucono δ-lactone, wherein the glucono δ-lactone is present in an amount of 5 to 99 wt % of the formulation. The invention also relates to a pharmaceutical formulation according to the invention for use in the prevention or treatment of a urogenital fungal infection. Furthermore, the invention relates to glucono δ-lactone (formula (III)), for use in the in the prevention or treatment of a fungal infection.
-
3.发明授权公开(公告)号：US11612584B2
公开(公告)日：2023-03-28
申请号：US16753899
申请日：2018-10-05
申请人： GEDEA BIOTECH AB
发明人： Ulf Ellervik , Olov Sterner , Helena Strevens , Sophie Manner
IPC分类号： A61K31/366 , A61P31/04 , A61K31/191 , A61K31/765 , A61K9/00 , A61K45/06
摘要： The present invention concerns a pharmaceutical composition comprising a compound of Formula I for use in the treatment and/or prevention of microbial infections. Furthermore, the present invention concerns a method for prevention and/or reduction of biofilm formation.
-
公开(公告)号：US20220193031A1
公开(公告)日：2022-06-23
申请号：US17601521
申请日：2020-04-03
申请人： GEDEA BIOTECH AB
发明人： Ulf Ellervik , Sophie Manner , Olov Sterner , Helena Strevens , Nils-Olof Lindberg , Annette Säfholm
IPC分类号： A61K31/366 , A61K9/00 , A61K9/20 , A61P31/04 , A61P31/10
摘要： The present invention concerns a pharmaceutical composition comprising glucono-δ-lactone, which is suitable for use in the treatment of vaginal microbial infections.
-
公开(公告)号：US20210212937A1
公开(公告)日：2021-07-15
申请号：US17218739
申请日：2021-03-31
申请人： Gedea Biotech AB
发明人： Ulf Ellervik , Olov Sterner , Helena Strevens , Sophie Manner
IPC分类号： A61K9/00 , F27D1/16 , F27B14/00 , F27B14/10 , H05B6/24 , F27B14/06 , F27B3/12 , A61K31/366 , A61P31/10 , A61K9/02 , A61K9/20 , A61K31/351 , A61K31/4164 , A61K31/4174 , A61K31/4196 , A61K31/496 , A61K31/513 , A61K31/7004
摘要： The present invention relates to a pharmaceutical formulation for vaginal administration, wherein the formulation comprises a pharmaceutical acceptable excipient and glucono δ-lactone, wherein the glucono δ-lactone is present in an amount of 5 to 99 wt % of the formulation. The invention also relates to a pharmaceutical formulation according to the invention for use in the prevention or treatment of a urogenital fungal infection. Furthermore, the invention relates to glucono δ-lactone (formula (III)), for use in the in the prevention or treatment of a fungal infection.
-
公开(公告)号：US10993907B2
公开(公告)日：2021-05-04
申请号：US16089194
申请日：2017-04-06
申请人： GEDEA BIOTECH AB
发明人： Ulf Ellervik , Olov Sterner , Helena Strevens , Sophie Manner
IPC分类号： A61K9/00 , A61K9/02 , A61K9/20 , A61K31/7004 , A61K31/4174 , A61K31/496 , A61K31/4196 , A61K31/351 , A61K31/513 , A61K31/4164 , A61P31/10 , F27D1/16 , F27B14/00 , F27B14/10 , H05B6/24 , F27B14/06 , F27B3/12 , A61K31/366 , F27B14/08
摘要： The present invention relates to a pharmaceutical formulation for vaginal administration, wherein the formulation comprises a pharmaceutical acceptable excipient and glucono δ-lactone, wherein the glucono δ-lactone is present in an amount of 5 to 99 wt % of the formulation. The invention also relates to a pharmaceutical formulation according to the invention for use in the prevention or treatment of a urogenital fungal infection. Furthermore, the invention relates to glucono δ-lactone (formula (III)), for use in the in the prevention or treatment of a fungal infection.
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.011 秒)
